Ligand validation:7PJI

IMP: INOSINIC ACID

IMP is a Ligand Of Interest in 7PJI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7PJI_IMP_A_602	78%	29%	0.107	0.949	1.42	1.41	2	5	4	0	100%	1
7PJI_IMP_B_602	71%	29%	0.127	0.949	1.44	1.41	2	5	1	0	100%	1
5AHN_IMP_A_1468	64%	4%	0.135	0.932	4.27	1.35	9	5	0	0	100%	0.8522
8QWA_IMP_A_501	100%	47%	0.038	0.987	1.01	1.04	3	3	0	0	100%	1
9DC8_IMP_A_801	100%	57%	0.041	0.985	0.82	0.83	-	-	0	0	100%	1
9DC9_IMP_A_801	99%	63%	0.044	0.983	0.66	0.77	-	-	1	0	100%	1
9C4M_IMP_G_801	99%	55%	0.051	0.982	0.94	0.79	1	-	0	0	100%	1
4FXS_IMP_A_701	98%	17%	0.056	0.98	1.71	1.89	4	7	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.